These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1094149)

  • 1. [Mechanism of leukocyte chemotaxis and congenital dyschemotaxis syndrome].
    Aoki T; Nakama S; Shimizu A
    Nihon Rinsho; 1975 Apr; 33(4):1598-614. PubMed ID: 1094149
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotaxis in cutaneous disease.
    Dahl MV
    Int J Dermatol; 1978 Mar; 17(2):95-104. PubMed ID: 348618
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemotaxis.
    Kretschmer RR; Collado ML
    Infection; 1980; 8 Suppl 3():S 299-302. PubMed ID: 6997207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukotaxis and leukotactic disorders. A review.
    Ward PA
    Am J Pathol; 1974 Dec; 77(3):520-38. PubMed ID: 4611227
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunodeficiencies in severe atopic dermatitis. Depressed chemotaxis and lymphocyte transformation.
    Rogge JL; Hanifin JM
    Arch Dermatol; 1976 Oct; 112(10):1391-6. PubMed ID: 962332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of leukocyte chemotaxis in vitro to assay mediators generated by immune reactions. I. Quantitation of mononuclear and polymorphonuclear leukocyte chemotaxis with polycarbonate (nuclepore) filters.
    Horwitz DA; Garrett MA
    J Immunol; 1971 Mar; 106(3):649-55. PubMed ID: 4926266
    [No Abstract]   [Full Text] [Related]  

  • 7. Leucocyte chemotaxis: physiological considerations and abnormalities.
    Gallin JI; Wolff SM
    Clin Haematol; 1975 Oct; 4(3):567-607. PubMed ID: 1201627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement function and disorders.
    Kehoe JM
    Pediatr Ann; 1976 Jun; 5(6):397-404. PubMed ID: 1272620
    [No Abstract]   [Full Text] [Related]  

  • 9. Modulation of macrophage C3b receptor function by cytochalasin-sensitive structures.
    Atkinson JP; Michael JM; Chaplin H; Parker CW
    J Immunol; 1977 Apr; 118(4):1292-9. PubMed ID: 557509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Present-day views on the physiopathology of the macrophage-monocyte system].
    Gorski A
    Pol Arch Med Wewn; 1977 Apr; 57(4):345-51. PubMed ID: 67594
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunological aspects of inflammatory granulomas (author's transl)].
    Nezelof C; Vildé F
    Arch Anat Cytol Pathol; 1976; 24(6):431-57. PubMed ID: 17369
    [No Abstract]   [Full Text] [Related]  

  • 12. [Complement system].
    Korol' SA
    Fiziol Zh; 1977; 23(3):408-16. PubMed ID: 326583
    [No Abstract]   [Full Text] [Related]  

  • 13. Prostaglandins and the modulation by cyclic nucleotides of lysosomal enzyme release.
    Weissmann G; Goldstein I; Hoffstein S
    Adv Prostaglandin Thromboxane Res; 1976; 2():803-14. PubMed ID: 983879
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on chemotaxis. Effect of subcellular leukocyte fractions on neutrophils and macrophages.
    Borel JF
    Int Arch Allergy Appl Immunol; 1970; 39(2-3):247-71. PubMed ID: 5471843
    [No Abstract]   [Full Text] [Related]  

  • 15. Stimulated neutrophil locomotion: chemokinesis and chemotaxis.
    Becker EL
    Arch Pathol Lab Med; 1977 Oct; 101(10):509-13. PubMed ID: 199132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of movement and maintenance of polarity in leucocytes.
    Allison AC
    Antibiot Chemother (1971); 1974; 19():191-217. PubMed ID: 4377081
    [No Abstract]   [Full Text] [Related]  

  • 17. Biochemistry and biological activity of the complement system.
    Surján M
    Ann Immunol Hung; 1973; 17():101-15. PubMed ID: 4618445
    [No Abstract]   [Full Text] [Related]  

  • 18. Human mononuclear leukocyte chemotaxis: a quantitative assay for humoral and cellular chemotactic factors.
    Snyderman R; Altman LC; Hausman MS; Mergenhagen SE
    J Immunol; 1972 Mar; 108(3):857-60. PubMed ID: 5011759
    [No Abstract]   [Full Text] [Related]  

  • 19. Complement C4-derived monocyte-directed chemotaxis-inhibitory factor. A molecular mechanism to cause polymorphonuclear leukocyte-predominant infiltration in rheumatoid arthritis synovial cavities.
    Matsubara S; Yamamoto T; Tsuruta T; Takagi K; Kambara T
    Am J Pathol; 1991 May; 138(5):1279-91. PubMed ID: 2024711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage phagocytic function and dysfunction.
    Axline SG
    Ariz Med; 1977 Apr; 31(4):253-5. PubMed ID: 849170
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.